A, O., Z, W., HC, G., AF, P., Y, Y., M, S., . . . H, C. (2026). MHC class II and PLA2R investigating the epitope presentation deficits driving antibody production in membranous nephropathy. International urology and nephrology. https://doi.org/10.1007/s11255-026-05100-9
Chicago Style (17th ed.) CitationA, Ouzaouit, et al. "MHC Class II and PLA2R Investigating the Epitope Presentation Deficits Driving Antibody Production in Membranous Nephropathy." International Urology and Nephrology 2026. https://doi.org/10.1007/s11255-026-05100-9.
MLA (9th ed.) CitationA, Ouzaouit, et al. "MHC Class II and PLA2R Investigating the Epitope Presentation Deficits Driving Antibody Production in Membranous Nephropathy." International Urology and Nephrology, 2026, https://doi.org/10.1007/s11255-026-05100-9.